Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study

Joel R. Rosh*, Dan Turner, Anne Griffiths, Stanley A. Cohen, Douglas Jacobstein, Omoniyi J. Adedokun, Lakshmi Padgett, Natalie A. Terry, Christopher O'Brien, Jeffrey S. Hyams

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science